Sort   by:  
 Page size 
UnknownTim-3 mediates T cell trogocytosis to limit antitumor immunity.
Not available
S-EPMC9057587 | biostudies-literature
UnknownGal9/Tim-3 expression level is higher in AML patients who fail chemotherapy.
Not available
S-EPMC6621946 | biostudies-literature
UnknownImmune checkpoint TIM-3 regulates microglia and Alzheimer's disease.
Not available
S-EPMC12079183 | biostudies-literature
UnknownRenal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+ T Cells With Expression of Exhaustion Markers.
Not available
S-EPMC6275222 | biostudies-literature
UnknownHigh-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors.
Not available
S-EPMC6170179 | biostudies-literature
UnknownPD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients.
Not available
S-EPMC10922154 | biostudies-literature
UnknownFunctional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme.
Not available
S-EPMC5589094 | biostudies-literature
UnknownDynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade.
Not available
S-EPMC9300827 | biostudies-literature
UnknownEfficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma Patients.
Not available
S-EPMC8158123 | biostudies-literature
UnknownImmune microenvironment of Epstein-Barr virus (EBV)-negative compared to EBV-associated gastric cancers: implications for immunotherapy.
Not available
S-EPMC11580252 | biostudies-literature
Sort   by:  
 Page size